SCHEMBL31728557

SCHEMBL31728557

Cn1cnc(COc2ccc(-c3ccn4nccc4c3F)c3ncnc(N)c23)n1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RPS6KA1 Q15418 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31728594 0.82 SRC (0.35) —
SCHEMBL31727822 0.81 EIF2AK3 (0.31) —
SCHEMBL31728482 0.79 — —
SCHEMBL31727802 0.74 SRC (0.34) —
SCHEMBL31728043 0.71 LRRK2 (0.31) —
SCHEMBL31728572 0.70 — —
SCHEMBL31728091 0.69 MAP4K4 (0.36) —
SCHEMBL31728886 0.68 KDR (0.34) —
SCHEMBL31727943 0.66 PIK3CD (0.35) —
SCHEMBL31728767 0.66 PIK3CD (0.41) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025235874-A1 HETEROCYCLICS AS EGFR INHIBITORS SCHRÖDINGER, INC. (US) 2025-11-13 — — WO disclosed
Send feedback